id	sid	tid	token	lemma	pos
egc-44	1	1	eglobal	eglobal	PROPN
egc-44	1	2	congress	congress	PROPN
egc-44	1	3	hosted	host	VERB
egc-44	1	4	online	online	ADV
egc-44	1	5	from	from	ADP
egc-44	1	6	dubai	dubai	PROPN
egc-44	1	7	,	,	PUNCT
egc-44	1	8	u.	u.	PROPN
egc-44	1	9	a.	a.	PROPN
egc-44	1	10	e.	e.	PROPN
egc-44	1	11	,	,	PUNCT
egc-44	1	12	e	e	PROPN
egc-44	1	13	conference	conference	NOUN
egc-44	1	14	.	.	PUNCT
egc-44	2	1	date	date	NOUN
egc-44	2	2	:	:	PUNCT
egc-44	2	3	19th	19th	ADJ
egc-44	2	4	february	february	PROPN
egc-44	2	5	,	,	PUNCT
egc-44	2	6	2023	2023	NUM
egc-44	2	7	website	website	NOUN
egc-44	2	8	:	:	PUNCT
egc-44	2	9	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-44	2	10	issn	issn	PROPN
egc-44	2	11	(	(	PUNCT
egc-44	2	12	e	e	NOUN
egc-44	2	13	):	):	PUNCT
egc-44	2	14	2836	2836	NUM
egc-44	2	15	-	-	SYM
egc-44	2	16	3612	3612	NUM
egc-44	2	17	93	93	NUM
egc-44	3	1	|	|	ADV
egc-44	3	2	p	p	ADP
egc-44	3	3	a	a	DET
egc-44	3	4	g	g	NOUN
egc-44	3	5	e	e	NOUN
egc-44	3	6	use	use	NOUN
egc-44	3	7	of	of	ADP
egc-44	3	8	urinary	urinary	ADJ
egc-44	3	9	kallidinogenase	kallidinogenase	NOUN
egc-44	3	10	in	in	ADP
egc-44	3	11	combination	combination	NOUN
egc-44	3	12	with	with	ADP
egc-44	3	13	rivaroxaban	rivaroxaban	NOUN
egc-44	3	14	in	in	ADP
egc-44	3	15	patients	patient	NOUN
egc-44	3	16	with	with	ADP
egc-44	3	17	brain	brain	NOUN
egc-44	3	18	infarction	infarction	NOUN
egc-44	3	19	avezova	avezova	PROPN
egc-44	3	20	s.	s.	PROPN
egc-44	3	21	y.	y.	PROPN
egc-44	3	22	urgench	urgench	PROPN
egc-44	3	23	branch	branch	PROPN
egc-44	3	24	of	of	ADP
egc-44	3	25	the	the	DET
egc-44	3	26	tashkent	tashkent	PROPN
egc-44	3	27	medical	medical	PROPN
egc-44	3	28	academy	academy	PROPN
egc-44	3	29	,	,	PUNCT
egc-44	3	30	urgench	urgench	NOUN
egc-44	3	31	e	e	NOUN
egc-44	3	32	-	-	NOUN
egc-44	3	33	mail	mail	NOUN
egc-44	3	34	:	:	PUNCT
egc-44	3	35	arhideya-07@mail.ru	arhideya-07@mail.ru	X
egc-44	4	1	тел.+998995608292	тел.+998995608292	VERB
egc-44	4	2	relevance	relevance	NOUN
egc-44	4	3	stroke	stroke	NOUN
egc-44	4	4	is	be	AUX
egc-44	4	5	an	an	DET
egc-44	4	6	extremely	extremely	ADV
egc-44	4	7	common	common	ADJ
egc-44	4	8	disease	disease	NOUN
egc-44	4	9	throughout	throughout	ADP
egc-44	4	10	the	the	DET
egc-44	4	11	world	world	NOUN
egc-44	4	12	.	.	PUNCT
egc-44	5	1	disability	disability	NOUN
egc-44	5	2	from	from	ADP
egc-44	5	3	a	a	DET
egc-44	5	4	stroke	stroke	NOUN
egc-44	5	5	ranks	rank	VERB
egc-44	5	6	first	first	ADV
egc-44	5	7	among	among	ADP
egc-44	5	8	the	the	DET
egc-44	5	9	causes	cause	NOUN
egc-44	5	10	of	of	ADP
egc-44	5	11	primary	primary	ADJ
egc-44	5	12	disability	disability	NOUN
egc-44	5	13	,	,	PUNCT
egc-44	5	14	reaching	reach	VERB
egc-44	5	15	,	,	PUNCT
egc-44	5	16	according	accord	VERB
egc-44	5	17	to	to	ADP
egc-44	5	18	different	different	ADJ
egc-44	5	19	authors	author	NOUN
egc-44	5	20	,	,	PUNCT
egc-44	5	21	up	up	ADV
egc-44	5	22	to	to	PART
egc-44	5	23	40	40	NUM
egc-44	5	24	%	%	NOUN
egc-44	5	25	,	,	PUNCT
egc-44	5	26	only	only	ADV
egc-44	5	27	8	8	NUM
egc-44	5	28	%	%	NOUN
egc-44	5	29	of	of	ADP
egc-44	5	30	surviving	survive	VERB
egc-44	5	31	patients	patient	NOUN
egc-44	5	32	are	be	AUX
egc-44	5	33	able	able	ADJ
egc-44	5	34	to	to	PART
egc-44	5	35	return	return	VERB
egc-44	5	36	to	to	ADP
egc-44	5	37	their	their	PRON
egc-44	5	38	previous	previous	ADJ
egc-44	5	39	work	work	NOUN
egc-44	5	40	after	after	ADP
egc-44	5	41	suffering	suffer	VERB
egc-44	5	42	an	an	DET
egc-44	5	43	acute	acute	ADJ
egc-44	5	44	circulatory	circulatory	ADJ
egc-44	5	45	disorder	disorder	NOUN
egc-44	5	46	.	.	PUNCT
egc-44	6	1	to	to	ADP
egc-44	6	2	date	date	NOUN
egc-44	6	3	,	,	PUNCT
egc-44	6	4	the	the	DET
egc-44	6	5	introduction	introduction	NOUN
egc-44	6	6	of	of	ADP
egc-44	6	7	new	new	ADJ
egc-44	6	8	methods	method	NOUN
egc-44	6	9	of	of	ADP
egc-44	6	10	treatment	treatment	NOUN
egc-44	6	11	contributes	contribute	VERB
egc-44	6	12	to	to	ADP
egc-44	6	13	the	the	DET
egc-44	6	14	success	success	NOUN
egc-44	6	15	of	of	ADP
egc-44	6	16	stroke	stroke	NOUN
egc-44	6	17	treatment	treatment	NOUN
egc-44	6	18	and	and	CCONJ
egc-44	6	19	greater	great	ADJ
egc-44	6	20	patient	patient	ADJ
egc-44	6	21	survival	survival	NOUN
egc-44	6	22	.	.	PUNCT
egc-44	7	1	objective	objective	NOUN
egc-44	7	2	:	:	PUNCT
egc-44	7	3	to	to	PART
egc-44	7	4	evaluate	evaluate	VERB
egc-44	7	5	the	the	DET
egc-44	7	6	clinical	clinical	ADJ
egc-44	7	7	efficacy	efficacy	NOUN
egc-44	7	8	of	of	ADP
egc-44	7	9	urinary	urinary	ADJ
egc-44	7	10	callidinogenase	callidinogenase	NOUN
egc-44	7	11	(	(	PUNCT
egc-44	7	12	kalgen	kalgen	X
egc-44	7	13	0.15	0.15	NUM
egc-44	7	14	pna	pna	PROPN
egc-44	7	15	)	)	PUNCT
egc-44	7	16	in	in	ADP
egc-44	7	17	combination	combination	NOUN
egc-44	7	18	with	with	ADP
egc-44	7	19	rivaroxaban	rivaroxaban	NOUN
egc-44	7	20	in	in	ADP
egc-44	7	21	patients	patient	NOUN
egc-44	7	22	with	with	ADP
egc-44	7	23	cerebral	cerebral	ADJ
egc-44	7	24	infarction	infarction	NOUN
egc-44	7	25	.	.	PUNCT
egc-44	8	1	materials	material	NOUN
egc-44	8	2	and	and	CCONJ
egc-44	8	3	methods	method	NOUN
egc-44	8	4	:	:	PUNCT
egc-44	8	5	in	in	ADP
egc-44	8	6	the	the	DET
egc-44	8	7	intensive	intensive	ADJ
egc-44	8	8	care	care	NOUN
egc-44	8	9	unit	unit	NOUN
egc-44	8	10	of	of	ADP
egc-44	8	11	the	the	DET
egc-44	8	12	clinic	clinic	NOUN
egc-44	8	13	of	of	ADP
egc-44	8	14	the	the	DET
egc-44	8	15	urgench	urgench	NOUN
egc-44	8	16	branch	branch	NOUN
egc-44	8	17	of	of	ADP
egc-44	8	18	tma	tma	PROPN
egc-44	8	19	,	,	PUNCT
egc-44	8	20	we	we	PRON
egc-44	8	21	examined	examine	VERB
egc-44	8	22	32	32	NUM
egc-44	8	23	patients	patient	NOUN
egc-44	8	24	with	with	ADP
egc-44	8	25	acute	acute	ADJ
egc-44	8	26	ischemic	ischemic	ADJ
egc-44	8	27	stroke	stroke	NOUN
egc-44	8	28	(	(	PUNCT
egc-44	8	29	20	20	NUM
egc-44	8	30	men	man	NOUN
egc-44	8	31	and	and	CCONJ
egc-44	8	32	12	12	NUM
egc-44	8	33	women	woman	NOUN
egc-44	8	34	)	)	PUNCT
egc-44	8	35	,	,	PUNCT
egc-44	8	36	whose	whose	DET
egc-44	8	37	average	average	ADJ
egc-44	8	38	age	age	NOUN
egc-44	8	39	was	be	AUX
egc-44	8	40	56,1±6,4	56,1±6,4	NUM
egc-44	8	41	years	year	NOUN
egc-44	8	42	.	.	PUNCT
egc-44	9	1	we	we	PRON
egc-44	9	2	divided	divide	VERB
egc-44	9	3	all	all	DET
egc-44	9	4	patients	patient	NOUN
egc-44	9	5	into	into	ADP
egc-44	9	6	2	2	NUM
egc-44	9	7	groups	group	NOUN
egc-44	9	8	:	:	PUNCT
egc-44	9	9	the	the	DET
egc-44	9	10	control	control	NOUN
egc-44	9	11	group	group	NOUN
egc-44	9	12	(	(	PUNCT
egc-44	9	13	retrospective	retrospective	NOUN
egc-44	9	14	)	)	PUNCT
egc-44	9	15	,	,	PUNCT
egc-44	9	16	which	which	PRON
egc-44	9	17	included	include	VERB
egc-44	9	18	16	16	NUM
egc-44	9	19	patients	patient	NOUN
egc-44	9	20	,	,	PUNCT
egc-44	9	21	received	receive	VERB
egc-44	9	22	standard	standard	ADJ
egc-44	9	23	therapy	therapy	NOUN
egc-44	9	24	,	,	PUNCT
egc-44	9	25	where	where	SCONJ
egc-44	9	26	we	we	PRON
egc-44	9	27	studied	study	VERB
egc-44	9	28	archival	archival	NOUN
egc-44	9	29	data	datum	NOUN
egc-44	9	30	,	,	PUNCT
egc-44	9	31	and	and	CCONJ
egc-44	9	32	the	the	DET
egc-44	9	33	study	study	NOUN
egc-44	9	34	group	group	NOUN
egc-44	9	35	,	,	PUNCT
egc-44	9	36	which	which	PRON
egc-44	9	37	included	include	VERB
egc-44	9	38	the	the	DET
egc-44	9	39	remaining	remain	VERB
egc-44	9	40	16	16	NUM
egc-44	9	41	,	,	PUNCT
egc-44	9	42	who	who	PRON
egc-44	9	43	,	,	PUNCT
egc-44	9	44	in	in	ADP
egc-44	9	45	addition	addition	NOUN
egc-44	9	46	to	to	ADP
egc-44	9	47	the	the	DET
egc-44	9	48	indicated	indicate	VERB
egc-44	9	49	therapy	therapy	NOUN
egc-44	9	50	,	,	PUNCT
egc-44	9	51	received	receive	VERB
egc-44	9	52	kalgen	kalgen	X
egc-44	9	53	0.15	0.15	NUM
egc-44	9	54	pna	pna	NOUN
egc-44	9	55	(	(	PUNCT
egc-44	9	56	urinary	urinary	ADJ
egc-44	9	57	kallidinogenase	kallidinogenase	NOUN
egc-44	9	58	)	)	PUNCT
egc-44	9	59	once	once	ADV
egc-44	9	60	a	a	DET
egc-44	9	61	day	day	NOUN
egc-44	9	62	in	in	ADP
egc-44	9	63	dilution	dilution	NOUN
egc-44	9	64	with	with	ADP
egc-44	9	65	physiological	physiological	ADJ
egc-44	9	66	saline	saline	NOUN
egc-44	9	67	intravenously	intravenously	ADV
egc-44	9	68	,	,	PUNCT
egc-44	9	69	drip	drip	NOUN
egc-44	9	70	,	,	PUNCT
egc-44	9	71	slowly	slowly	ADV
egc-44	9	72	.	.	PUNCT
egc-44	10	1	for	for	ADP
egc-44	10	2	the	the	DET
egc-44	10	3	purpose	purpose	NOUN
egc-44	10	4	of	of	ADP
egc-44	10	5	anticoagulant	anticoagulant	ADJ
egc-44	10	6	therapy	therapy	NOUN
egc-44	10	7	in	in	ADP
egc-44	10	8	patients	patient	NOUN
egc-44	10	9	of	of	ADP
egc-44	10	10	the	the	DET
egc-44	10	11	study	study	NOUN
egc-44	10	12	group	group	NOUN
egc-44	10	13	,	,	PUNCT
egc-44	10	14	we	we	PRON
egc-44	10	15	used	use	VERB
egc-44	10	16	rivaroxaban	rivaroxaban	NOUN
egc-44	10	17	20	20	NUM
egc-44	10	18	mg	mg	NOUN
egc-44	10	19	tablets	tablet	NOUN
egc-44	10	20	once	once	ADV
egc-44	10	21	a	a	DET
egc-44	10	22	day	day	NOUN
egc-44	10	23	for	for	ADP
egc-44	10	24	20	20	NUM
egc-44	10	25	days	day	NOUN
egc-44	10	26	.	.	PUNCT
egc-44	11	1	we	we	PRON
egc-44	11	2	measured	measure	VERB
egc-44	11	3	icp	icp	PROPN
egc-44	11	4	non	non	ADJ
egc-44	11	5	-	-	ADJ
egc-44	11	6	invasively	invasively	ADV
egc-44	11	7	using	use	VERB
egc-44	11	8	the	the	DET
egc-44	11	9	komplexmed	komplexme	VERB
egc-44	11	10	1.2	1.2	NUM
egc-44	11	11	apparatus	apparatus	NOUN
egc-44	11	12	by	by	ADP
egc-44	11	13	m	m	NOUN
egc-44	11	14	-	-	NOUN
egc-44	11	15	echo	echo	NOUN
egc-44	11	16	of	of	ADP
egc-44	11	17	the	the	DET
egc-44	11	18	pulsation	pulsation	NOUN
egc-44	11	19	of	of	ADP
egc-44	11	20	the	the	DET
egc-44	11	21	3rd	3rd	ADJ
egc-44	11	22	ventricle	ventricle	NOUN
egc-44	11	23	of	of	ADP
egc-44	11	24	the	the	DET
egc-44	11	25	brain	brain	NOUN
egc-44	11	26	(	(	PUNCT
egc-44	11	27	normal	normal	ADJ
egc-44	11	28	,	,	PUNCT
egc-44	11	29	moderate	moderate	ADJ
egc-44	11	30	and	and	CCONJ
egc-44	11	31	pronounced	pronounced	ADJ
egc-44	11	32	increase	increase	NOUN
egc-44	11	33	in	in	ADP
egc-44	11	34	icp	icp	PROPN
egc-44	11	35	)	)	PUNCT
egc-44	11	36	.	.	PUNCT
egc-44	12	1	all	all	DET
egc-44	12	2	patients	patient	NOUN
egc-44	12	3	underwent	undergo	VERB
egc-44	12	4	clinical	clinical	ADJ
egc-44	12	5	and	and	CCONJ
egc-44	12	6	biochemical	biochemical	ADJ
egc-44	12	7	studies	study	NOUN
egc-44	12	8	,	,	PUNCT
egc-44	12	9	computed	compute	VERB
egc-44	12	10	tomography	tomography	NOUN
egc-44	12	11	,	,	PUNCT
egc-44	12	12	during	during	ADP
egc-44	12	13	therapy	therapy	NOUN
egc-44	12	14	,	,	PUNCT
egc-44	12	15	coagulogram	coagulogram	PROPN
egc-44	12	16	(	(	PUNCT
egc-44	12	17	aptt	aptt	PROPN
egc-44	12	18	,	,	PUNCT
egc-44	12	19	fibrinogen	fibrinogen	PROPN
egc-44	12	20	,	,	PUNCT
egc-44	12	21	pti	pti	PROPN
egc-44	12	22	)	)	PUNCT
egc-44	12	23	,	,	PUNCT
egc-44	12	24	blood	blood	NOUN
egc-44	12	25	pressure	pressure	NOUN
egc-44	12	26	,	,	PUNCT
egc-44	12	27	mean	mean	VERB
egc-44	12	28	arterial	arterial	ADJ
egc-44	12	29	pressure	pressure	NOUN
egc-44	12	30	,	,	PUNCT
egc-44	12	31	blood	blood	NOUN
egc-44	12	32	glucose	glucose	NOUN
egc-44	12	33	,	,	PUNCT
egc-44	12	34	thermometry	thermometry	NOUN
egc-44	12	35	and	and	CCONJ
egc-44	12	36	venous	venous	ADJ
egc-44	12	37	blood	blood	NOUN
egc-44	12	38	saturation	saturation	NOUN
egc-44	12	39	were	be	AUX
egc-44	12	40	monitored	monitor	VERB
egc-44	12	41	.	.	PUNCT
egc-44	13	1	we	we	PRON
egc-44	13	2	assessed	assess	VERB
egc-44	13	3	neurostatus	neurostatus	NOUN
egc-44	13	4	using	use	VERB
egc-44	13	5	the	the	DET
egc-44	13	6	glasgow	glasgow	ADJ
egc-44	13	7	scale	scale	NOUN
egc-44	13	8	and	and	CCONJ
egc-44	13	9	nihss	nihss	ADJ
egc-44	13	10	.	.	PUNCT
egc-44	14	1	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	ADJ
egc-44	14	2	mailto:arhideya-07@mail.ru	mailto:arhideya-07@mail.ru	PROPN
egc-44	14	3	eglobal	eglobal	PROPN
egc-44	14	4	congress	congress	PROPN
egc-44	14	5	hosted	host	VERB
egc-44	14	6	online	online	ADV
egc-44	14	7	from	from	ADP
egc-44	14	8	dubai	dubai	PROPN
egc-44	14	9	,	,	PUNCT
egc-44	14	10	u.	u.	PROPN
egc-44	14	11	a.	a.	PROPN
egc-44	14	12	e.	e.	PROPN
egc-44	14	13	,	,	PUNCT
egc-44	14	14	e	e	PROPN
egc-44	14	15	conference	conference	NOUN
egc-44	14	16	.	.	PUNCT
egc-44	15	1	date	date	NOUN
egc-44	15	2	:	:	PUNCT
egc-44	15	3	19th	19th	ADJ
egc-44	15	4	february	february	PROPN
egc-44	15	5	,	,	PUNCT
egc-44	15	6	2023	2023	NUM
egc-44	15	7	website	website	NOUN
egc-44	15	8	:	:	PUNCT
egc-44	15	9	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-44	15	10	issn	issn	PROPN
egc-44	15	11	(	(	PUNCT
egc-44	15	12	e	e	NOUN
egc-44	15	13	):	):	PUNCT
egc-44	15	14	2836	2836	NUM
egc-44	15	15	-	-	SYM
egc-44	15	16	3612	3612	NUM
egc-44	15	17	94	94	NUM
egc-44	16	1	|	|	ADV
egc-44	16	2	p	p	NOUN
egc-44	16	3	a	a	DET
egc-44	16	4	g	g	NOUN
egc-44	16	5	e	e	NOUN
egc-44	16	6	results	result	NOUN
egc-44	16	7	:	:	PUNCT
egc-44	16	8	according	accord	VERB
egc-44	16	9	to	to	ADP
egc-44	16	10	the	the	DET
egc-44	16	11	data	datum	NOUN
egc-44	16	12	obtained	obtain	VERB
egc-44	16	13	in	in	ADP
egc-44	16	14	patients	patient	NOUN
egc-44	16	15	in	in	ADP
egc-44	16	16	the	the	DET
egc-44	16	17	study	study	NOUN
egc-44	16	18	group	group	NOUN
egc-44	16	19	,	,	PUNCT
egc-44	16	20	kalgen	kalgen	PROPN
egc-44	16	21	0,15	0,15	PROPN
egc-44	16	22	pna	pna	PROPN
egc-44	16	23	in	in	ADP
egc-44	16	24	combination	combination	NOUN
egc-44	16	25	with	with	ADP
egc-44	16	26	rivaroxaban	rivaroxaban	NOUN
egc-44	16	27	20	20	NUM
egc-44	16	28	mg	mg	NOUN
egc-44	16	29	had	have	VERB
egc-44	16	30	a	a	DET
egc-44	16	31	positive	positive	ADJ
egc-44	16	32	effect	effect	NOUN
egc-44	16	33	on	on	ADP
egc-44	16	34	the	the	DET
egc-44	16	35	recovery	recovery	NOUN
egc-44	16	36	of	of	ADP
egc-44	16	37	cognitive	cognitive	ADJ
egc-44	16	38	functions	function	NOUN
egc-44	16	39	on	on	ADP
egc-44	16	40	days	day	NOUN
egc-44	16	41	3	3	NUM
egc-44	16	42	-	-	SYM
egc-44	16	43	6	6	NUM
egc-44	16	44	,	,	PUNCT
egc-44	16	45	and	and	CCONJ
egc-44	16	46	in	in	ADP
egc-44	16	47	the	the	DET
egc-44	16	48	control	control	NOUN
egc-44	16	49	group	group	NOUN
egc-44	16	50	,	,	PUNCT
egc-44	16	51	positive	positive	ADJ
egc-44	16	52	dynamics	dynamic	NOUN
egc-44	16	53	according	accord	VERB
egc-44	16	54	to	to	ADP
egc-44	16	55	the	the	DET
egc-44	16	56	glasgow	glasgow	ADJ
egc-44	16	57	and	and	CCONJ
egc-44	16	58	nihss	nihss	ADJ
egc-44	16	59	scales	scale	NOUN
egc-44	16	60	were	be	AUX
egc-44	16	61	noted	note	VERB
egc-44	16	62	on	on	ADP
egc-44	16	63	days	day	NOUN
egc-44	16	64	6	6	NUM
egc-44	16	65	-	-	SYM
egc-44	16	66	8	8	NUM
egc-44	16	67	.	.	PUNCT
egc-44	17	1	in	in	ADP
egc-44	17	2	the	the	DET
egc-44	17	3	study	study	NOUN
egc-44	17	4	group	group	NOUN
egc-44	17	5	,	,	PUNCT
egc-44	17	6	a	a	DET
egc-44	17	7	decrease	decrease	NOUN
egc-44	17	8	in	in	ADP
egc-44	17	9	plasma	plasma	NOUN
egc-44	17	10	fibrinogen	fibrinogen	NOUN
egc-44	17	11	and	and	CCONJ
egc-44	17	12	pti	pti	PROPN
egc-44	17	13	was	be	AUX
egc-44	17	14	observed	observe	VERB
egc-44	17	15	in	in	ADP
egc-44	17	16	dynamics	dynamic	NOUN
egc-44	17	17	by	by	ADP
egc-44	17	18	48,1	48,1	NOUN
egc-44	17	19	%	%	NOUN
egc-44	17	20	and	and	CCONJ
egc-44	17	21	15,4	15,4	NUM
egc-44	17	22	%	%	NOUN
egc-44	17	23	,	,	PUNCT
egc-44	17	24	respectively	respectively	ADV
egc-44	17	25	,	,	PUNCT
egc-44	17	26	and	and	CCONJ
egc-44	17	27	an	an	DET
egc-44	17	28	increase	increase	NOUN
egc-44	17	29	in	in	ADP
egc-44	17	30	the	the	DET
egc-44	17	31	time	time	NOUN
egc-44	17	32	of	of	ADP
egc-44	17	33	apt	apt	ADJ
egc-44	17	34	by	by	ADP
egc-44	17	35	21,9	21,9	NUM
egc-44	17	36	%	%	NOUN
egc-44	17	37	on	on	ADP
egc-44	17	38	days	day	NOUN
egc-44	17	39	3	3	NUM
egc-44	17	40	-	-	SYM
egc-44	17	41	4	4	NUM
egc-44	17	42	of	of	ADP
egc-44	17	43	treatment	treatment	NOUN
egc-44	17	44	,	,	PUNCT
egc-44	17	45	while	while	SCONJ
egc-44	17	46	in	in	ADP
egc-44	17	47	the	the	DET
egc-44	17	48	control	control	NOUN
egc-44	17	49	group	group	NOUN
egc-44	17	50	these	these	DET
egc-44	17	51	changes	change	NOUN
egc-44	17	52	were	be	AUX
egc-44	17	53	noted	note	VERB
egc-44	17	54	on	on	ADP
egc-44	17	55	days	day	NOUN
egc-44	17	56	5	5	NUM
egc-44	17	57	-	-	SYM
egc-44	17	58	6	6	NUM
egc-44	17	59	.	.	PUNCT
egc-44	18	1	conclusions	conclusion	NOUN
egc-44	18	2	:	:	PUNCT
egc-44	19	1	1	1	X
egc-44	19	2	.	.	PUNCT
egc-44	19	3	kalgen	kalgen	NOUN
egc-44	19	4	0.15	0.15	NUM
egc-44	19	5	pna	pna	NOUN
egc-44	19	6	has	have	VERB
egc-44	19	7	a	a	DET
egc-44	19	8	positive	positive	ADJ
egc-44	19	9	effect	effect	NOUN
egc-44	19	10	on	on	ADP
egc-44	19	11	the	the	DET
egc-44	19	12	recovery	recovery	NOUN
egc-44	19	13	of	of	ADP
egc-44	19	14	cognitive	cognitive	ADJ
egc-44	19	15	functions	function	NOUN
egc-44	19	16	at	at	ADP
egc-44	19	17	an	an	DET
egc-44	19	18	earlier	early	ADJ
egc-44	19	19	time	time	NOUN
egc-44	19	20	in	in	ADP
egc-44	19	21	patients	patient	NOUN
egc-44	19	22	with	with	ADP
egc-44	19	23	cerebral	cerebral	ADJ
egc-44	19	24	infarction	infarction	NOUN
egc-44	19	25	.	.	PUNCT
egc-44	20	1	2	2	X
egc-44	20	2	.	.	X
egc-44	20	3	the	the	DET
egc-44	20	4	use	use	NOUN
egc-44	20	5	of	of	ADP
egc-44	20	6	rivaroxaban	rivaroxaban	NOUN
egc-44	20	7	20	20	NUM
egc-44	20	8	mg	mg	NOUN
egc-44	20	9	in	in	ADP
egc-44	20	10	combination	combination	NOUN
egc-44	20	11	with	with	ADP
egc-44	20	12	kalgen	kalgen	PROPN
egc-44	20	13	0.15	0.15	NUM
egc-44	20	14	pna	pna	NOUN
egc-44	20	15	improves	improve	VERB
egc-44	20	16	hemostasis	hemostasis	NOUN
egc-44	20	17	at	at	ADP
egc-44	20	18	an	an	DET
egc-44	20	19	earlier	early	ADJ
egc-44	20	20	stage	stage	NOUN
egc-44	20	21	of	of	ADP
egc-44	20	22	treatment	treatment	NOUN
egc-44	20	23	.	.	PUNCT
egc-44	21	1	literature	literature	NOUN
egc-44	21	2	:	:	PUNCT
egc-44	21	3	1	1	X
egc-44	21	4	.	.	X
egc-44	21	5	отажонов	отажонов	NOUN
egc-44	21	6	,	,	PUNCT
egc-44	21	7	и	и	PROPN
egc-44	21	8	.	.	PUNCT
egc-44	22	1	о	о	X
egc-44	22	2	.	.	PUNCT
egc-44	23	1	(	(	PUNCT
egc-44	23	2	2011	2011	NUM
egc-44	23	3	)	)	PUNCT
egc-44	23	4	.	.	PUNCT
egc-44	24	1	заболеваемость	заболеваемость	NOUN
egc-44	24	2	студентов	студентов	NOUN
egc-44	24	3	по	по	ADP
egc-44	24	4	материалам	материалам	NOUN
egc-44	24	5	углубленного	углубленного	NOUN
egc-44	24	6	медосмотра	медосмотра	NOUN
egc-44	24	7	студентов	студентов	NOUN
egc-44	24	8	,	,	PUNCT
egc-44	24	9	обучающихся	обучающихся	NOUN
egc-44	24	10	в	в	PROPN
egc-44	24	11	высших	высших	PROPN
egc-44	24	12	учебных	учебных	PROPN
egc-44	24	13	заведениях	заведениях	PROPN
egc-44	24	14	.	.	PUNCT
egc-44	25	1	тошкент	тошкент	PROPN
egc-44	25	2	тиббиёт	тиббиёт	PROPN
egc-44	25	3	академияси	академияси	PROPN
egc-44	25	4	ахборотномаси.–тошкент	ахборотномаси.–тошкент	PROPN
egc-44	25	5	,	,	PUNCT
egc-44	25	6	(	(	PUNCT
egc-44	25	7	2	2	NUM
egc-44	25	8	)	)	PUNCT
egc-44	25	9	,	,	PUNCT
egc-44	25	10	122	122	NUM
egc-44	25	11	-	-	SYM
egc-44	25	12	126	126	NUM
egc-44	25	13	.	.	NOUN
egc-44	26	1	2	2	NUM
egc-44	26	2	.	.	NUM
egc-44	26	3	islamovna	islamovna	NOUN
egc-44	26	4	,	,	PUNCT
egc-44	26	5	s.	s.	PROPN
egc-44	26	6	g.	g.	PROPN
egc-44	26	7	,	,	PUNCT
egc-44	26	8	komildjanovich	komildjanovich	PROPN
egc-44	26	9	,	,	PUNCT
egc-44	26	10	z.	z.	PROPN
egc-44	26	11	a.	a.	PROPN
egc-44	26	12	,	,	PUNCT
egc-44	26	13	otaboevich	otaboevich	PROPN
egc-44	26	14	,	,	PUNCT
egc-44	26	15	o.	o.	PROPN
egc-44	26	16	i.	i.	PROPN
egc-44	26	17	,	,	PUNCT
egc-44	26	18	&	&	CCONJ
egc-44	26	19	fatihovich	fatihovich	PROPN
egc-44	26	20	,	,	PUNCT
egc-44	26	21	z.	z.	PROPN
egc-44	26	22	j.	j.	PROPN
egc-44	26	23	(	(	PUNCT
egc-44	26	24	2016	2016	NUM
egc-44	26	25	)	)	PUNCT
egc-44	26	26	.	.	PUNCT
egc-44	27	1	characteristics	characteristic	NOUN
egc-44	27	2	of	of	ADP
egc-44	27	3	social	social	ADJ
egc-44	27	4	and	and	CCONJ
egc-44	27	5	living	living	NOUN
egc-44	27	6	conditions	condition	NOUN
egc-44	27	7	,	,	PUNCT
egc-44	27	8	the	the	DET
egc-44	27	9	incidence	incidence	NOUN
egc-44	27	10	of	of	ADP
egc-44	27	11	patients	patient	NOUN
egc-44	27	12	with	with	ADP
egc-44	27	13	crf	crf	PROPN
egc-44	27	14	.	.	PROPN
egc-44	27	15	european	european	PROPN
egc-44	27	16	science	science	PROPN
egc-44	27	17	review	review	PROPN
egc-44	27	18	,	,	PUNCT
egc-44	27	19	(	(	PUNCT
egc-44	27	20	3	3	NUM
egc-44	27	21	-	-	SYM
egc-44	27	22	4	4	NUM
egc-44	27	23	)	)	PUNCT
egc-44	27	24	,	,	PUNCT
egc-44	27	25	142	142	NUM
egc-44	27	26	-	-	SYM
egc-44	27	27	144	144	NUM
egc-44	27	28	.	.	PUNCT
egc-44	28	1	3	3	X
egc-44	28	2	.	.	X
egc-44	28	3	отажонов	отажонов	NOUN
egc-44	28	4	,	,	PUNCT
egc-44	28	5	и	и	PROPN
egc-44	28	6	.	.	PUNCT
egc-44	29	1	о	о	X
egc-44	29	2	.	.	PUNCT
egc-44	30	1	(	(	PUNCT
egc-44	30	2	2020	2020	NUM
egc-44	30	3	)	)	PUNCT
egc-44	30	4	.	.	PUNCT
egc-44	31	1	кaм	кaм	PROPN
egc-44	31	2	оқсилли	оқсилли	PROPN
egc-44	31	3	парҳез	парҳез	PROPN
egc-44	31	4	самарадорлигини	самарадорлигини	NOUN
egc-44	31	5	баҳолаш	баҳолаш	VERB
egc-44	31	6	.	.	PUNCT
egc-44	32	1	4	4	X
egc-44	32	2	.	.	X
egc-44	32	3	отажонов	отажонов	NOUN
egc-44	32	4	,	,	PUNCT
egc-44	32	5	и	и	PROPN
egc-44	32	6	.	.	PUNCT
egc-44	33	1	о	о	PROPN
egc-44	33	2	.	.	PROPN
egc-44	33	3	,	,	PUNCT
egc-44	33	4	&	&	CCONJ
egc-44	33	5	шайхова	шайхова	NOUN
egc-44	33	6	,	,	PUNCT
egc-44	33	7	г	г	PROPN
egc-44	33	8	.	.	PUNCT
egc-44	33	9	и	и	PROPN
egc-44	33	10	.	.	PUNCT
egc-44	34	1	(	(	PUNCT
egc-44	34	2	2020	2020	NUM
egc-44	34	3	)	)	PUNCT
egc-44	34	4	.	.	PUNCT
egc-44	35	1	фактическое	фактическое	PROPN
egc-44	35	2	питание	питание	PROPN
egc-44	35	3	больных	больных	PROPN
egc-44	35	4	с	с	PROPN
egc-44	35	5	хронической	хронической	VERB
egc-44	35	6	болезнью	болезнью	ADJ
egc-44	35	7	почек	почек	NOUN
egc-44	35	8	.	.	PUNCT
egc-44	36	1	медицинские	медицинские	PROPN
egc-44	36	2	новости	новости	PROPN
egc-44	36	3	,	,	PUNCT
egc-44	36	4	(	(	PUNCT
egc-44	36	5	5	5	NUM
egc-44	36	6	(	(	PUNCT
egc-44	36	7	308	308	NUM
egc-44	36	8	)	)	PUNCT
egc-44	36	9	)	)	PUNCT
egc-44	36	10	,	,	PUNCT
egc-44	36	11	52	52	NUM
egc-44	36	12	-	-	SYM
egc-44	36	13	54	54	NUM
egc-44	36	14	.	.	PUNCT
egc-44	37	1	5	5	NUM
egc-44	37	2	.	.	X
egc-44	37	3	отажонов	отажонов	NOUN
egc-44	37	4	,	,	PUNCT
egc-44	37	5	и	и	PROPN
egc-44	37	6	.	.	PUNCT
egc-44	38	1	о	о	X
egc-44	38	2	.	.	PUNCT
egc-44	39	1	(	(	PUNCT
egc-44	39	2	2020	2020	NUM
egc-44	39	3	)	)	PUNCT
egc-44	39	4	.	.	PUNCT
egc-44	40	1	оценка	оценка	ADV
egc-44	40	2	психологического	психологического	VERB
egc-44	40	3	состояния	состояния	ADV
egc-44	40	4	больных	больных	NOUN
egc-44	40	5	с	с	PROPN
egc-44	40	6	хронической	хронической	VERB
egc-44	40	7	болезнью	болезнью	ADJ
egc-44	40	8	почек	почек	NOUN
egc-44	40	9	.	.	PUNCT
egc-44	41	1	главный	главный	PROPN
egc-44	41	2	редактор	редактор	PROPN
egc-44	41	3	–	–	PUNCT
egc-44	41	4	жа	жа	X
egc-44	41	5	ризаев	ризаев	NOUN
egc-44	41	6	,	,	PUNCT
egc-44	41	7	145	145	NUM
egc-44	41	8	.	.	NOUN
egc-44	42	1	6	6	NUM
egc-44	42	2	.	.	X
egc-44	42	3	отажонов	отажонов	NOUN
egc-44	42	4	,	,	PUNCT
egc-44	42	5	и	и	PROPN
egc-44	42	6	.	.	PUNCT
egc-44	43	1	о	о	X
egc-44	43	2	.	.	PUNCT
egc-44	44	1	(	(	PUNCT
egc-44	44	2	2021	2021	NUM
egc-44	44	3	)	)	PUNCT
egc-44	44	4	.	.	PUNCT
egc-44	45	1	сурункали	сурункали	PROPN
egc-44	45	2	буйрак	буйрак	VERB
egc-44	45	3	касаллиги	касаллиги	PROPN
egc-44	45	4	бўлган	бўлган	PROPN
egc-44	45	5	беморлар	беморлар	PROPN
egc-44	45	6	ҳаёт	ҳаёт	PROPN
egc-44	45	7	сифати	сифати	ADJ
egc-44	45	8	кўрсаткичлари	кўрсаткичлари	NOUN
egc-44	45	9	.	.	PUNCT
egc-44	46	1	7	7	X
egc-44	46	2	.	.	X
egc-44	46	3	отажонов	отажонов	NOUN
egc-44	46	4	,	,	PUNCT
egc-44	46	5	и	и	PROPN
egc-44	46	6	.	.	PUNCT
egc-44	47	1	о	о	X
egc-44	47	2	.	.	PUNCT
egc-44	48	1	(	(	PUNCT
egc-44	48	2	2010	2010	NUM
egc-44	48	3	)	)	PUNCT
egc-44	48	4	.	.	PUNCT
egc-44	49	1	характеристика	характеристика	ADJ
egc-44	49	2	фактического	фактического	VERB
egc-44	49	3	питания	питания	ADJ
egc-44	49	4	и	и	PROPN
egc-44	49	5	качественный	качественный	ADJ
egc-44	49	6	анализ	анализ	NOUN
egc-44	49	7	нутриентов	нутриентов	NOUN
egc-44	49	8	в	в	PROPN
egc-44	49	9	рационе	рационе	VERB
egc-44	49	10	питания	питания	ADJ
egc-44	49	11	студентов	студентов	PROPN
egc-44	49	12	высших	высших	PROPN
egc-44	49	13	учебных	учебных	PROPN
egc-44	49	14	заведений	заведений	PROPN
egc-44	49	15	.	.	PUNCT
egc-44	50	1	врач	врач	NOUN
egc-44	50	2	-	-	PUNCT
egc-44	50	3	аспирант	аспирант	NOUN
egc-44	50	4	,	,	PUNCT
egc-44	50	5	43(6.2	43(6.2	NOUN
egc-44	50	6	)	)	PUNCT
egc-44	50	7	,	,	PUNCT
egc-44	50	8	278	278	NUM
egc-44	50	9	-	-	SYM
egc-44	50	10	285	285	NUM
egc-44	50	11	.	.	PUNCT
egc-44	51	1	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-44	51	2	eglobal	eglobal	PROPN
egc-44	51	3	congress	congress	PROPN
egc-44	51	4	hosted	host	VERB
egc-44	51	5	online	online	ADV
egc-44	51	6	from	from	ADP
egc-44	51	7	dubai	dubai	PROPN
egc-44	51	8	,	,	PUNCT
egc-44	51	9	u.	u.	PROPN
egc-44	51	10	a.	a.	PROPN
egc-44	51	11	e.	e.	PROPN
egc-44	51	12	,	,	PUNCT
egc-44	51	13	e	e	PROPN
egc-44	51	14	conference	conference	NOUN
egc-44	51	15	.	.	PUNCT
egc-44	52	1	date	date	NOUN
egc-44	52	2	:	:	PUNCT
egc-44	52	3	19th	19th	ADJ
egc-44	52	4	february	february	PROPN
egc-44	52	5	,	,	PUNCT
egc-44	52	6	2023	2023	NUM
egc-44	52	7	website	website	NOUN
egc-44	52	8	:	:	PUNCT
egc-44	52	9	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-44	52	10	issn	issn	PROPN
egc-44	52	11	(	(	PUNCT
egc-44	52	12	e	e	NOUN
egc-44	52	13	):	):	PUNCT
egc-44	52	14	2836	2836	NUM
egc-44	52	15	-	-	SYM
egc-44	52	16	3612	3612	NUM
egc-44	52	17	95	95	NUM
egc-44	53	1	|	|	ADV
egc-44	53	2	p	p	NOUN
egc-44	53	3	a	a	DET
egc-44	53	4	g	g	NOUN
egc-44	53	5	e	e	NOUN
egc-44	53	6	8	8	NUM
egc-44	53	7	.	.	PUNCT
egc-44	54	1	otajonov	otajonov	PROPN
egc-44	54	2	,	,	PUNCT
egc-44	54	3	i.	i.	PROPN
egc-44	54	4	,	,	PUNCT
egc-44	54	5	shaykhova	shaykhova	PROPN
egc-44	54	6	,	,	PUNCT
egc-44	54	7	g.	g.	PROPN
egc-44	54	8	,	,	PUNCT
egc-44	54	9	salomova	salomova	PROPN
egc-44	54	10	,	,	PUNCT
egc-44	54	11	f.	f.	PROPN
egc-44	54	12	,	,	PUNCT
egc-44	54	13	kurbanova	kurbanova	PROPN
egc-44	54	14	,	,	PUNCT
egc-44	54	15	k.	k.	PROPN
egc-44	54	16	,	,	PUNCT
egc-44	54	17	malokhat	malokhat	PROPN
egc-44	54	18	,	,	PUNCT
egc-44	54	19	n.	n.	NOUN
egc-44	54	20	,	,	PUNCT
egc-44	54	21	&	&	CCONJ
egc-44	54	22	kurbonov	kurbonov	PROPN
egc-44	54	23	,	,	PUNCT
egc-44	54	24	k.	k.	PROPN
egc-44	54	25	(	(	PUNCT
egc-44	54	26	2020	2020	NUM
egc-44	54	27	)	)	PUNCT
egc-44	54	28	.	.	PUNCT
egc-44	55	1	effectiveness	effectiveness	NOUN
egc-44	55	2	of	of	ADP
egc-44	55	3	diet	diet	NOUN
egc-44	55	4	in	in	ADP
egc-44	55	5	experimental	experimental	ADJ
egc-44	55	6	chronic	chronic	ADJ
egc-44	55	7	kidney	kidney	NOUN
egc-44	55	8	disease	disease	NOUN
egc-44	55	9	.	.	PUNCT
egc-44	56	1	european	european	ADJ
egc-44	56	2	journal	journal	PROPN
egc-44	56	3	of	of	ADP
egc-44	56	4	molecular	molecular	ADJ
egc-44	56	5	&	&	CCONJ
egc-44	56	6	clinical	clinical	ADJ
egc-44	56	7	medicine	medicine	NOUN
egc-44	56	8	,	,	PUNCT
egc-44	56	9	7(2	7(2	NUM
egc-44	56	10	)	)	PUNCT
egc-44	56	11	,	,	PUNCT
egc-44	56	12	1097	1097	NUM
egc-44	56	13	-	-	SYM
egc-44	56	14	1109	1109	NUM
egc-44	56	15	.	.	PUNCT
egc-44	57	1	9	9	X
egc-44	57	2	.	.	X
egc-44	57	3	отажонов	отажонов	NOUN
egc-44	57	4	,	,	PUNCT
egc-44	57	5	и	и	PROPN
egc-44	57	6	.	.	PUNCT
egc-44	57	7	(	(	PUNCT
egc-44	57	8	2011	2011	NUM
egc-44	57	9	)	)	PUNCT
egc-44	57	10	.	.	PUNCT
egc-44	58	1	ҳозирги	ҳозирги	ADJ
egc-44	58	2	тараққиёт	тараққиёт	NOUN
egc-44	58	3	даврида	даврида	NOUN
egc-44	58	4	талабалар	талабалар	NOUN
egc-44	58	5	овқатланишини	овқатланишини	NOUN
egc-44	58	6	гигиеник	гигиеник	ADP
egc-44	58	7	асослаш	асослаш	PROPN
egc-44	58	8	(	(	PUNCT
egc-44	58	9	doctoral	doctoral	ADJ
egc-44	58	10	dissertation	dissertation	NOUN
egc-44	58	11	,	,	PUNCT
egc-44	58	12	тошкент	тошкент	ADJ
egc-44	58	13	тиббиёт	тиббиёт	VERB
egc-44	58	14	академияси	академияси	NOUN
egc-44	58	15	)	)	PUNCT
egc-44	58	16	.	.	PUNCT
egc-44	59	1	10	10	NUM
egc-44	59	2	.	.	X
egc-44	60	1	akhmadalieva	akhmadalieva	PROPN
egc-44	60	2	,	,	PUNCT
egc-44	60	3	n.	n.	PROPN
egc-44	60	4	o.	o.	PROPN
egc-44	60	5	,	,	PUNCT
egc-44	60	6	salomova	salomova	PROPN
egc-44	60	7	,	,	PUNCT
egc-44	60	8	f.	f.	PROPN
egc-44	60	9	i.	i.	PROPN
egc-44	60	10	,	,	PUNCT
egc-44	60	11	sadullaeva	sadullaeva	PROPN
egc-44	60	12	,	,	PUNCT
egc-44	60	13	k.	k.	PROPN
egc-44	60	14	a.	a.	PROPN
egc-44	60	15	,	,	PUNCT
egc-44	60	16	abdukadirova	abdukadirova	PROPN
egc-44	60	17	,	,	PUNCT
egc-44	60	18	l.	l.	PROPN
egc-44	60	19	k.	k.	PROPN
egc-44	60	20	,	,	PUNCT
egc-44	60	21	toshmatova	toshmatova	PROPN
egc-44	60	22	,	,	PUNCT
egc-44	60	23	g.	g.	PROPN
egc-44	60	24	a.	a.	PROPN
egc-44	60	25	,	,	PUNCT
egc-44	60	26	&	&	CCONJ
egc-44	60	27	otajonov	otajonov	PROPN
egc-44	60	28	,	,	PUNCT
egc-44	60	29	i.	i.	PROPN
egc-44	60	30	o.	o.	PROPN
egc-44	60	31	(	(	PUNCT
egc-44	60	32	2021	2021	NUM
egc-44	60	33	)	)	PUNCT
egc-44	60	34	.	.	PUNCT
egc-44	61	1	health	health	NOUN
egc-44	61	2	state	state	NOUN
egc-44	61	3	of	of	ADP
egc-44	61	4	teaching	teaching	NOUN
egc-44	61	5	staff	staff	NOUN
egc-44	61	6	of	of	ADP
egc-44	61	7	different	different	ADJ
egc-44	61	8	universities	university	NOUN
egc-44	61	9	in	in	ADP
egc-44	61	10	the	the	DET
egc-44	61	11	republic	republic	NOUN
egc-44	61	12	of	of	ADP
egc-44	61	13	uzbekistan	uzbekistan	PROPN
egc-44	61	14	.	.	PUNCT
egc-44	62	1	nveonatural	nveonatural	ADJ
egc-44	62	2	volatiles	volatile	NOUN
egc-44	62	3	&	&	CCONJ
egc-44	62	4	essential	essential	ADJ
egc-44	62	5	oils	oil	NOUN
egc-44	62	6	journal|	journal|	NOUN
egc-44	62	7	nveo	nveo	NOUN
egc-44	62	8	,	,	PUNCT
egc-44	62	9	15954	15954	NUM
egc-44	62	10	-	-	SYM
egc-44	62	11	15967	15967	NUM
egc-44	62	12	.	.	PUNCT
egc-44	63	1	11	11	NUM
egc-44	63	2	.	.	X
egc-44	64	1	otajonov	otajonov	PROPN
egc-44	64	2	ilkhom	ilkhom	PROPN
egc-44	64	3	оtajonovich	оtajonovich	PROPN
egc-44	64	4	(	(	PUNCT
egc-44	64	5	2022	2022	NUM
egc-44	64	6	)	)	PUNCT
egc-44	64	7	.	.	PUNCT
egc-44	65	1	analysis	analysis	NOUN
egc-44	65	2	of	of	ADP
egc-44	65	3	the	the	DET
egc-44	65	4	diet	diet	NOUN
egc-44	65	5	of	of	ADP
egc-44	65	6	patients	patient	NOUN
egc-44	65	7	with	with	ADP
egc-44	65	8	chronic	chronic	ADJ
egc-44	65	9	kidney	kidney	NOUN
egc-44	65	10	disease	disease	NOUN
egc-44	65	11	.	.	PUNCT
egc-44	66	1	telematique	telematique	ADJ
egc-44	66	2	,	,	PUNCT
egc-44	66	3	21(1	21(1	NUM
egc-44	66	4	)	)	PUNCT
egc-44	66	5	,	,	PUNCT
egc-44	66	6	7639	7639	NUM
egc-44	66	7	-	-	SYM
egc-44	66	8	7643	7643	NUM
egc-44	66	9	.	.	PUNCT
egc-44	67	1	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN